ישראל - עברית - Ministry of Health

eli lilly israel ltd, israel - raloxifene hydrochloride - טבליות מצופות פילם - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - evista is indicated for the treatment of osteoporosis in post menopausal women. evista is indicated for the prevention of osteoporosis in post menopausal women . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.

ישראל - עברית - Ministry of Health

teva israel ltd - raloxifene hydrochloride - טבליה - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - - treatment of osteoporosis in post menopausal women. - prevention of osteoporosis in post menopausal women .

ישראל - עברית - Ministry of Health

teva israel ltd - raloxifene hydrochloride - טבליה - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - - treatment of osteoporosis in post menopausal women. - prevention of osteoporosis in post menopausal women .

ישראל - עברית - Ministry of Health

teva israel ltd - tamoxifen as citrate - טבליה - tamoxifen as citrate 20 mg - tamoxifen - tamoxifen - for the palliative treatment of breast cancer generally in post menopausal women, either alone or in combination with other modalities.

ישראל - עברית - Ministry of Health

teva israel ltd - raloxifene hydrochloride - טבליה - raloxifene hydrochloride 60 mg - raloxifene

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - raloxifene hydrochloride 60 mg - tablets - raloxifene - - treatment of osteoporosis in post menopausal women. - prevention of osteoporosis in post menopausal women .

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - tamoxifen as citrate 10 mg - tablets - tamoxifen - for the palliative treatment of breast cancer generally in post menopausal women, either alone or in combination with other modalities.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - tamoxifen as citrate 20 mg - tablets - tamoxifen - for the palliative treatment of breast cancer generally in post menopausal women, either alone or in combination with other modalities.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - exemestane - טבליות מצופות פילם - exemestane 25 mg - exemestane - exemestane - exemestane teva® is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane teva® is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies.exemestane teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy